Balanced news tone
News Sentiment
ONESOURCE sentiment intelligence
ONESOURCE SPECL PHARMA L news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
45
Balanced news tone
18 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-2.5% over one week, +0.9% over four weeks, trend active, and near fair-value range.
OneSource Falls 3% on Formycon Manufacturing Deal
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
-2.5%
Price reacting lower
Trend fit
Trend active
0.9% over four weeks
Fair value
-2.9%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
9
Negative
6
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Equitypandit
Direct company coverage
OneSource Falls 3% on Formycon Manufacturing Deal
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 14 Jul 2026 09:01
- Source
- Equitypandit
Equitypandit
Direct company coverage
OneSource Falls 7% Then Rebounds on Dr Reddy’s Delay
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 10 Jul 2026 09:01
- Source
- Equitypandit
CNBC TV18
Direct company coverage
Onesource shares fall up to 7% on semaglutide supply delay, guidance cut from key client
- Tone
- Negative 6/100
- Event
- Guidance
- Published
- 10 Jul 2026 05:49
- Source
- CNBC TV18
The Economic Times
Direct company coverage
Onesource Specialty Pharma - Positive Breakout: These 11 stocks cross above their 200 DMAs
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- The Economic Times
The Economic Times
Direct company coverage
Onesource Specialty Pharma - Negative Breakout: These 9 stocks drop below their 200 DMAs
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- The Economic Times
Moneycontrol.com
Direct company coverage
Why the Brooks Steriscience–OneSource deal was called off
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 25 May 2026 07:00
- Source
- Moneycontrol.com
simplywall.st
Direct company coverage
Analysts Expect OneSource Specialty Pharma Limited (NSE:ONESOURCE) To Breakeven Soon
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- simplywall.st
NDTV Profit
Direct company coverage
Five Stocks To Buy: Aurobindo Pharma, Tata Communications, Graphite India And More | May 18, 2026
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- NDTV Profit
Press Trust of India
Direct company coverage
TPG sells 8.84 lakh shares of Onesource Specialty Pharma for Rs 139 cr
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- Press Trust of India
scanx.trade
Direct company coverage
OneSource Specialty Pharma Board Decides Against Pursuing Composite Merger Scheme in Current Form
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 13 May 2026 07:00
- Source
- scanx.trade
CNBC TV18
Direct company coverage
OneSource Specialty Pharma shares fall as Q4 profit plunges 95%, margin halves
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- CNBC TV18
Stock Titan
Direct company coverage
$456M Leidos deal keeps Military OneSource serving 4.7M people
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 29 Apr 2026 07:00
- Source
- Stock Titan
The Economic Times
Direct company coverage
Onesource Specialty Pharma - 9 stocks with rising promoter pledges in March '26
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- The Economic Times
CNBC TV18
Direct company coverage
OneSource Specialty Pharma receives EU GMP certification for sterile product division
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- CNBC TV18
CNBC TV18
Direct company coverage
Explained: Why Onesource Specialty Pharma and Shaily Engineering stocks were in focus today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2026 07:00
- Source
- CNBC TV18
Business Standard
Direct company coverage
Onesource Specialty Pharma up 5% in weak market; rallies 21% in one week
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 24 Apr 2026 07:00
- Source
- Business Standard
CNBC TV18
Direct company coverage
Onesource Specialty Pharma shares gain after equity worth ₹408 crore changes hands in block deals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- CNBC TV18
Moneycontrol.com
Direct company coverage
Fidelity Securities Fund buys Rs 309 crore worth shares in Onesource Specialty Pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- Moneycontrol.com